4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Upstream Bio, Inc. (UPB) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 75 employees. Its market capitalization is roughly $425 million. In the fiscal year ended 2025-12-31, UPB reported $3M in revenue and ($143M) in net income.
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
Interactive charts & full statements → Open the UPB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $3M | $2M | $2M | $1M |
| Operating Income (EBIT) | ($160M) | ($78M) | ($40M) | ($24M) |
| Net Income | ($143M) | ($63M) | ($20M) | ($24M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($44M) | ($46M) | ($38M) | ($44M) | ($32M) | — |
| Net Income | ($41M) | ($42M) | ($34M) | ($40M) | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $354M | $482M | $117M | $18M |
| Total Liabilities | $14M | $12M | $240M | $125M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UPB viewer.
About TickerBase · Data methodology & sources